Free Trial

Trevi Therapeutics (TRVI) SEC Filings & 10K Form

Trevi Therapeutics logo
$6.99 +0.09 (+1.30%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$7.06 +0.08 (+1.07%)
As of 05/2/2025 07:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Trevi Therapeutics SEC Filings

DateFilerForm TypeView
04/29/2025
9:14 AM
Trevi Therapeutics (Filer)
Form DEF 14A
04/29/2025
9:22 AM
Trevi Therapeutics (Filer)
Form ARS
03/26/2025
3:30 PM
SCIASCIA THOMAS (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2025
3:30 PM
GOOD JENNIFER L (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
6:55 PM
New Enterprise Associates 16, L.P. (Filed by)
Trevi Therapeutics (Subject)
Form SCHEDULE 13D/A
03/18/2025
3:16 PM
Trevi Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/18/2025
3:10 PM
Trevi Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2025
4:03 PM
Trevi Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2025
3:32 PM
Simon Farrell (Reporting)
Trevi Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
5:04 PM
Trevi Therapeutics (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
Form SCHEDULE 13G/A
02/14/2025
10:21 AM
Frazier Life Sciences Public Fund, L.P. (Filed by)
Trevi Therapeutics (Subject)
Form SCHEDULE 13G/A
02/13/2025
12:41 PM
Rosalind Advisors, Inc. (Filed by)
Trevi Therapeutics (Subject)
Form SCHEDULE 13G/A
01/08/2025
7:00 AM
Trevi Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2024
3:30 PM
Galletta Christopher (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
4:20 PM
Trevi Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2024
4:18 PM
Trevi Therapeutics (Filer)
Form 424B5
12/12/2024
7:00 AM
Trevi Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2024
4:20 PM
Trevi Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
4:51 PM
Trevi Therapeutics (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
Form SC 13G/A
11/13/2024
3:30 PM
Rubric Capital Management LP (Filed by)
Trevi Therapeutics (Subject)
Form SC 13G/A
11/08/2024
5:57 PM
New Enterprise Associates 16, L.P. (Filed by)
Trevi Therapeutics (Subject)
Form SC 13D/A
11/06/2024
3:20 PM
Trevi Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
9:30 AM
Frazier Life Sciences Public Fund, L.P. (Filed by)
Trevi Therapeutics (Subject)
Form SC 13G/A
10/23/2024
1:44 PM
Rosalind Advisors, Inc. (Filed by)
Trevi Therapeutics (Subject)
Form SC 13G/A
10/21/2024
9:43 AM
Trevi Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
7:07 AM
Trevi Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
4:00 PM
GOOD JENNIFER L (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
3:54 PM
GOOD JENNIFER L (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
3:37 PM
GOOD JENNIFER L (Reporting)
Trevi Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/29/2024
3:55 PM
Meeker David P (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
3:10 PM
Meeker David P (Reporting)
Trevi Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/15/2024
4:14 PM
SCIASCIA THOMAS (Reporting)
Trevi Therapeutics (Subject)
Form 144/A
07/11/2024
4:52 PM
Rosalind Advisors, Inc. (Filed by)
Trevi Therapeutics (Subject)
Form SC 13G/A
07/10/2024
3:16 PM
MAI Capital Management (Filed by)
Trevi Therapeutics (Subject)
Form SCHEDULE 13G/A
06/14/2024
3:40 PM
Mathers Edward T (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:30 PM
Colangelo Dominick (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:30 PM
Trevi Therapeutics (Issuer)
VANLENT ANNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:30 PM
Meeker David P (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:30 PM
Heffernan Michael Thomas (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:30 PM
Cassella James V (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
3:30 PM
GOOD JENNIFER L (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad)

I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.

All the details are waiting for you now — but you need to act before the May 1st funding window clos
05/21/2024
5:34 PM
New Enterprise Associates 16, L.P. (Filed by)
Trevi Therapeutics (Subject)
Form SC 13D/A
05/14/2024
3:51 PM
GOOD JENNIFER L (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
3:09 PM
Trevi Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:TRVI) was last updated on 5/5/2025 by MarketBeat.com Staff
From Our Partners